CBPO

China Biologic Products Holdings, Inc.
CBPO

Overview Fund Activity
Delisted

CBPO was delisted on the 20th of April, 2021.

Back to rankings

82 hedge funds and large institutions have $1.38B invested in China Biologic Products Holdings, Inc. in 2018 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 31 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
82
Holders Change
-9
Holders Change %
-9.89%
% of All Funds
1.88%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
14
Increased
23
Reduced
31
Closed
23
Calls
$10M
Puts
$18.1M
Net Calls
-$8.1M
Net Calls Change
-$7.85M

Top Buyers

1
HIM
Hillhouse Investment Management
Cayman Islands
+$171M
2
HSBC Holdings
HSBC Holdings
United Kingdom
+$62.4M
3
Bank of America
Bank of America
North Carolina
+$53.9M
4
Capital World Investors
Capital World Investors
California
+$27.5M
5
YCMGA
York Capital Management Global Advisors
New York
+$27.2M

Top Sellers

1
Capital Research Global Investors
Capital Research Global Investors
California
-$49.6M
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$37.2M
3
JAM
Jupiter Asset Management
United Kingdom
-$25M
4
BCIM
Black Creek Investment Management
Ontario, Canada
-$23.9M
5
Macquarie Group
Macquarie Group
Australia
-$18.3M
Name Holding Trade Value Shares
Change 		Shares
Change %
SEI Investments
101
SEI Investments
Pennsylvania
– -$120K -1,206 Closed
AF
102
Advisornet Financial
Minnesota
– -$90K -910 Closed
Envestnet Asset Management
103
Envestnet Asset Management
Illinois
– -$77K -778 Closed
Manulife (Manufacturers Life Insurance)
104
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$11K -111 Closed
1 2 3 4
5